Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.

The association of anti-EGFR to gemcitabine and oxaliplatin (GEMOX) chemotherapy did not improve survival in biliary tract carcinoma (BTC) patients. Multiple mechanisms might be involved in the resistance to anti-EGFR. Here, we explored the mutation profile of EGFR extracellular domain (ECD), of tyr...

Full description

Bibliographic Details
Main Authors:	Caterina Peraldo-Neia, Giuliana Cavalloni, Elisabetta Fenocchio, Celeste Cagnazzo, Loretta Gammaitoni, Stefano Cereda, Guglielmo Nasti, Maria Antonietta Satolli, Giuseppe Aprile, Michele Reni, Antonio Avallone, Rosella Spadi, Tiziana Venesio, Vittoria Martin, Claudio Doglioni, Milo Frattini, Massimo Aglietta, Francesco Leone
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5774843?pdf=render

Similar Items

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
by: Cavalloni Giuliana, et al.
Published: (2011-01-01)

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
by: Bardelli Alberto, et al.
Published: (2010-11-01)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition.
by: Alessandro eOttaiano, et al.
Published: (2013-01-01)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
by: Anbang Wang, et al.
Published: (2020-01-01)

EGFR-TKIs resistance via EGFR-independent signaling pathways
by: Qian Liu, et al.
Published: (2018-02-01)

Effect of EGFR-TKI on Lymphangiogenesis of Lung Cancer with EGFR Mutation
by: Minghui CAI, et al.
Published: (2014-12-01)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
by: Wen M, et al.
Published: (2018-11-01)

Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
by: Chiara Varamo, et al.
Published: (2019-04-01)

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
by: Wang Fen, et al.
Published: (2012-08-01)

Characterisation and regulation of the Egfr/Egfr ligand system in fish models for melanoma
by: Laisney, Juliette Agnès Geneviève Claire
Published: (2010)

Distinguish EGFR+ and EGFR- Patients in Lung adenocarcinoma using CT Images
by: Ting-Wei Weng, et al.
Published: (2017)

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction.
by: Shang-Gin Wu, et al.
Published: (2011-01-01)

EGFR is not amplified in ameloblastoma
by: Abreu Alves, F., et al.
Published: (2018)

EGFR and SOX2 crosstalk determines EGFR-TKI sensitivity and tumor progression
by: LEE, AN-CHUN, et al.
Published: (2018)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
by: Beth O. Van Emburgh, et al.
Published: (2016-12-01)

THE PHARMACOGENOMICS OF EGFR-DEPENDENT NSCLC: PREDICTING AND ENHANCING RESPONSE TO TARGETED EGFR THERAPY
by: Balko, Justin M.
Published: (2009)

The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.
by: Xiaofei Chang, et al.
Published: (2013-01-01)

An investigation of EGFR binding and modulation of EGFR signalling pathways using synthetic peptides
by: Hamilton, S. J.
Published: (2004)

Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
by: Takahiro Yoshizawa, et al.
Published: (2021-04-01)

Evaluation of 7q31 region improves the accuracy of <it>EGFR </it>FISH assay in non small cell lung cancer
by: Venesio Tiziana, et al.
Published: (2009-11-01)

EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
by: Ali-Osman Francis, et al.
Published: (2011-03-01)

Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis
by: Xishan Chen, et al.
Published: (2021-08-01)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
by: Xu H, et al.
Published: (2020-08-01)

A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo
by: Yu-Ping Yang, et al.
Published: (2017-05-01)

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
by: Milica Momcilovic, et al.
Published: (2017-01-01)

Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
by: Chengjuan Zhang, et al.
Published: (2017-01-01)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
by: Fu-Tsai Chung, et al.
Published: (2015-01-01)

Characterization of the Small Compounds -T315 on EGFR Degradation in EGFR-TKI Resistant Lung Adenocarcinoma
by: Kuo-Yen Huang, et al.
Published: (2015)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
by: Liang Shi, et al.
Published: (2021-03-01)

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
by: Xiaojing Du, et al.
Published: (2021-05-01)

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
by: Cheng WC, et al.
Published: (2021-01-01)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
by: Alessandro Ottaiano, et al.
Published: (2018-05-01)

Emerging functions of the EGFR in cancer
by: Sara Sigismund, et al.
Published: (2018-01-01)

Role of EGFR in the Nervous System
by: Roberta Romano, et al.
Published: (2020-08-01)

Targeting EGFR in Esophagogastric Cancer
by: Steven B. Maron, et al.
Published: (2020-12-01)

EGFR Signaling in Liver Diseases
by: Karin Komposch, et al.
Published: (2015-12-01)

EGFR Mutations and Lung Cancer.
Published: (2005-11-01)

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies.
by: Steffen Grann Jensen, et al.
Published: (2021-01-01)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> Mutations
by: Kenichi Suda, et al.
Published: (2021-06-01)

HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs
by: Sho Watanabe, et al.
Published: (2021-03-01)